Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: humanized anti-HER2 antibody|DRUG: Vinorelbine
Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd.